Enhancing engagement in hepatitis C care among people who inject drugs

Alison D Marshall^{1

2}, Annie Madden², Carla Treloar²

Affiliations

¹ The Kirby Institute, University of New South Wales, Sydney, Australia.
² Centre for Social Research in Health, University of New South Wales, Sydney, Australia.

Editorial

Alison D Marshall et al. Addiction. 2019 Dec.

. 2019 Dec;114(12):2104-2106.

doi: 10.1111/add.14698. Epub 2019 Jun 26.

Alison D Marshall^{1

2}, Annie Madden², Carla Treloar²

¹ The Kirby Institute, University of New South Wales, Sydney, Australia.
² Centre for Social Research in Health, University of New South Wales, Sydney, Australia.

No abstract available

Keywords: Barriers to care; Hepatitis C infection; direct-acting antivirals; health services; models of care; people who inject drugs.

References

1. World Health Organization. Global health sector strategy on viral hepatitis 2016-2021. Towards ending viral hepatitis. June 2016. Available at: http://www.who.int/hepatitis/strategy2016-2021/ghss-hep/en/ (accessed 21 May 2017).
1. Grebely J., Larney S., Peacock A., Colledge S., Leung J., Hickman M. et al. Global, regional, and country-level estimates of hepatitis C infection among people who have recently injected drugs. Addiction 2019; 114: 150-166.
1. Treloar C., Rance J., Backmund M. Understanding barriers to hepatitis C virus care and stigmatization from a social perspective. Clin Infect Dis 2013; 57: S51-S55.
1. Baum F., Fisher M. Why behavioural health promotion endures despite its failure to reduce health inequities. Sociol Health Illn 2014; 36: 213-225.
1. Bryant J., Saxton M., Madden A., Bath N., Robinson S. Consumers' and providers' perspectives about consumer participation in drug treatment services: is there support to do more? What are the obstacles? Drug Alcohol Rev 2008; 27: 138-144.